Shulman De Meo Asset Management LLC Enzo Biochem Inc Transaction History
Shulman De Meo Asset Management LLC
- $406 Million
- Q3 2024
A detailed history of Shulman De Meo Asset Management LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Shulman De Meo Asset Management LLC holds 15,487 shares of ENZ stock, worth $11,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,487
Previous 15,487
-0.0%
Holding current value
$11,150
Previous $16,000
6.25%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ENZ
# of Institutions
48Shares Held
15.5MCall Options Held
2.3KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$3.73 Million3.43% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$1.82 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$1.35 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.07 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$960,8249.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $35.1M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...